Home

DISCOVERSeq

DISCOVERSeq is a software framework and workflow platform intended to support discovery-based genomic research through end-to-end processing of sequencing data, variant discovery, and reporting. The project emphasizes modularity, reproducibility, and interoperability with standard data formats, enabling researchers to assemble customized analyses from reusable components.

Overview and scope: DISCOVERSeq supports multiple sequencing modalities, including short-read, long-read, and single-cell data. It provides

Development and governance: Initiated by the Genomic Discovery Initiative, DISCOVERSeq is an open-source project maintained by

Features and architecture: Core components include data ingest modules, alignment and variant-calling engines, functional annotation, and

Impact and challenges: In academia and clinical research, DISCOVERSeq is used to accelerate discovery in cancer

See also: genomics, bioinformatics, sequencing technologies, data provenance.

data
quality
control,
alignment
or
mapping,
variant
calling,
annotation,
and
result
interpretation
within
a
single
coherent
environment.
Workflows
are
described
in
portable
formats
to
enhance
portability
and
provenance,
and
can
be
executed
on
local
clusters,
high-performance
computing
resources,
or
cloud
platforms.
a
community
of
researchers
and
developers.
Contributions
are
coordinated
through
documentation,
versioning,
and
issue
tracking
to
support
collaborative
development.
The
project
is
designed
to
interoperate
with
common
file
formats
(FASTQ/BAM/CRAM,
VCF,
GTF/GFF)
and
widely
used
tools
in
bioinformatics.
visualization
dashboards.
The
platform
emphasizes
scalable
execution,
reproducible
workflows,
and
audit
trails
for
provenance.
It
supports
modular
plug-ins,
enabling
users
to
swap
algorithms
or
add
new
data
types
while
preserving
a
consistent
interface.
genomics,
rare
diseases,
and
population
studies.
As
with
similar
platforms,
it
requires
substantial
computational
resources
and
careful
attention
to
data
privacy
and
analytic
choices.